Predicting Escitalopram Exposure to Breastfeeding Infants: Integrating Analytical and In Silico Techniques
Autor: | David Colantonio, Paul R. V. Malik, Cristiana Stefan, Andrea N. Edginton, Shinya Ito, Sarah R. Delaney |
---|---|
Rok vydání: | 2018 |
Předmět: |
Adult
Physiologically based pharmacokinetic modelling Time Factors Population Breastfeeding Physiology Citalopram Breast milk Models Biological 030226 pharmacology & pharmacy Depression Postpartum 03 medical and health sciences 0302 clinical medicine Tandem Mass Spectrometry mental disorders Humans Lactation Medicine Escitalopram Computer Simulation Pharmacology (medical) education 2. Zero hunger Pharmacology education.field_of_study Milk Human business.industry Infant Newborn Area under the curve Infant Infant exposure Breast Feeding Area Under Curve 030220 oncology & carcinogenesis Female Drug Monitoring business Breast feeding Selective Serotonin Reuptake Inhibitors Chromatography Liquid medicine.drug |
Zdroj: | Clinical Pharmacokinetics. 57:1603-1611 |
ISSN: | 1179-1926 0312-5963 |
DOI: | 10.1007/s40262-018-0657-2 |
Popis: | Escitalopram is used for post-partum depression; however, there are limited pharmacokinetic data of escitalopram in milk and plasma of infants breastfed by women taking the drug. The objective of this study was to apply physiologically-based pharmacokinetic (PBPK) modelling to predict infant drug exposure (plasma area under the curve from time zero to infinity [AUC∞]) based on drug monitoring data of escitalopram in breast milk. Using a newly developed liquid chromatography-tandem mass spectrometry (LC-MS/MS) method, we quantified escitalopram concentrations in milk samples of 18 breastfeeding women with escitalopram therapy at steady state, collected at three to five time points. The escitalopram concentrations in breast milk were used with infant feeding parameters from the literature to simulate infant daily dose. We used PK-Sim® to develop an adult PBPK model for escitalopram and extrapolated it to a population of 1600 infants up to 12 months of age. An integration of the simulated infant daily dose and the virtual infants with variable physiological–pharmacological parameters was used to predict drug exposure (plasma AUC∞) distribution in the population of infants breastfed by women receiving escitalopram 20 mg/day. Escitalopram concentrations in milk were 50 ± 17 ng/mL (mean ± standard deviation). The simulated infant plasma AUC∞ following escitalopram exposure through breast milk was low, with a median of 1.7% (range 0.5–5.9%) of the corresponding maternal plasma AUC∞, indicating no substantial exposure. Infant exposure levels to escitalopram in breast milk are low. A PBPK modeling approach can be used to translate data on drug monitoring in milk into a population distribution of infant plasma levels for drug safety assessment. |
Databáze: | OpenAIRE |
Externí odkaz: |